Search

Search Constraints

You searched for: Author/Creator Aringer, Martin

Search Results

1. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Issue 9 (2nd September 2019)

2. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Issue 9 (5th August 2019)

3. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Issue 9 (6th August 2019)

4. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Issue 6 (29th March 2019)

5. 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis. Issue 6 (27th March 2020)

6. 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Issue 1 (24th November 2021)

7. 272 Acute phase reactant levels and prednisone doses at disease flare in patients with giant cell arteritis: prospective data from the GiACTA trial. (12th April 2019)

8. 351. EFFECTS OF BASELINE PREDNISONE DOSE ON REMISSION AND DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB IN A PHASE 3 RANDOMIZED CONTROLLED TRIAL. (29th March 2019)

9. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). Issue 3 (24th November 2016)